{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:25:04Z","timestamp":1714436704216},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00108-024-01681-8","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T15:02:11Z","timestamp":1709910131000},"page":"517-523","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Arzneimitteltherapie von arterieller Hypertonie und Vorhofflimmern bei gebrechlichen Patienten","Drug therapy for arterial hypertension and atrial fibrillation in frail patients"],"prefix":"10.1007","volume":"65","author":[{"given":"Ursula","family":"M\u00fcller-Werdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"issue":"10305","key":"1681_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","volume":"398","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration (2021) Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet 398(10305):1053\u20131064. https:\/\/doi.org\/10.1016\/S0140-6736(21)01921-8","journal-title":"Lancet"},{"issue":"1","key":"1681_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/a-1120-0779","volume":"146","author":"H Burkhardt","year":"2021","unstructured":"Burkhardt\u00a0H (2021) Polypharmazie \u2013 Was tun? [How to manage polypharmacia?]. Dtsch Med Wochenschr 146(1):15\u201322. https:\/\/doi.org\/10.1055\/a-1120-0779","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"1681_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11357-021-00420-3","volume":"44","author":"S Choi","year":"2022","unstructured":"Choi\u00a0S, Baudot\u00a0M, Vivas\u00a0O, Moreno\u00a0CM (2022) Slowing down as we age: aging of the cardiac pacemaker\u2019s neural control. Geroscience 44(1):1\u201317. https:\/\/doi.org\/10.1007\/s11357-021-00420-3","journal-title":"Geroscience"},{"issue":"12","key":"1681_CR4","doi-asserted-by":"publisher","first-page":"e724","DOI":"10.1016\/S2666-7568(23)00208-8","volume":"4","author":"M Denkinger","year":"2023","unstructured":"Denkinger\u00a0M, Knol\u00a0W, Cherubini\u00a0A, Simonds\u00a0A, Lionis\u00a0C, Lacombe\u00a0D, Petelos\u00a0E, McCarthy\u00a0M, Ouvrard\u00a0P, Van Kerrebroeck\u00a0P, Szyma\u0144ski\u00a0P, Cupelli\u00a0A, Laslop\u00a0A, Koch\u00a0A, Sepodes\u00a0B, Torre\u00a0C, R\u00f6nnemaa\u00a0E, Ba\u0142kowiec-Iskra\u00a0E, Herdeiro\u00a0MT, Rosa\u00a0MM, Trauffler\u00a0M, Miro\u0161evi\u0107 Skvrce\u00a0N, Mayrhofer\u00a0S, Berntgen\u00a0M, Silva\u00a0I, Cerreta\u00a0F (2023) Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults. Lancet Healthy Longev 4(12):e724\u2013e729. https:\/\/doi.org\/10.1016\/S2666-7568(23)00208-8","journal-title":"Lancet Healthy Longev"},{"key":"1681_CR5","unstructured":"DGK (2018) https:\/\/leitlinien.dgk.org\/files\/28_2018_pocket_leitlinien_arterielle_hypertonie_aktualisiert.pdf"},{"key":"1681_CR6","unstructured":"DGK (2020) https:\/\/leitlinien.dgk.org\/files\/21_2020_pocket_leitlinien_vorhofflimmern_korrigiert.pdf"},{"issue":"4","key":"1681_CR7","doi-asserted-by":"publisher","first-page":"371.e1","DOI":"10.1016\/j.jamda.2017.12.013","volume":"19","author":"M de Vries","year":"2018","unstructured":"de Vries\u00a0M, Seppala\u00a0LJ, Daams\u00a0JG, van de Glind\u00a0EMM, Masud\u00a0T, van der Velde\u00a0N, EUGMS Task and Finish Group on Fall-Risk-Increasing Drugs (2018) Fall-risk-increasing drugs: a\u00a0systematic review and meta-analysis: I.\u00a0cardiovascular drugs. J\u00a0Am Med Dir Assoc 19(4):371.e1\u2013371.e9. https:\/\/doi.org\/10.1016\/j.jamda.2017.12.013","journal-title":"J Am Med Dir Assoc"},{"issue":"25","key":"1681_CR8","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/eurheartj\/ehz071","volume":"40","author":"A Douros","year":"2019","unstructured":"Douros\u00a0A, T\u00f6lle\u00a0M, Ebert\u00a0N, Gaedeke\u00a0J, Huscher\u00a0D, Kreutz\u00a0R, Kuhlmann\u00a0MK, Martus\u00a0P, Mielke\u00a0N, Schneider\u00a0A, Schuchardt\u00a0M, van der Giet\u00a0M, Schaeffner\u00a0E (2019) Control of blood pressure and risk of mortality in a\u00a0cohort of older adults: the Berlin Initiative Study. Eur Heart\u00a0J 40(25):2021\u20132028. https:\/\/doi.org\/10.1093\/eurheartj\/ehz071 (Erratum in: Eur Heart J. 2020 Dec 7;41(46):4422)","journal-title":"Eur Heart J"},{"issue":"3","key":"1681_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40262-023-01222-w","volume":"62","author":"AE Edwina","year":"2023","unstructured":"Edwina\u00a0AE, Dia\u00a0N, Dreesen\u00a0E, Vanassche\u00a0T, Verhamme\u00a0P, Spriet\u00a0I, Van der Linden\u00a0L, Tournoy\u00a0J (2023) Insights into the pharmacokinetics and pharmacodynamics of direct oral anticoagulants in older adults with atrial fibrillation: a\u00a0structured narrative review. Clin Pharmacokinet 62(3):351\u2013373. https:\/\/doi.org\/10.1007\/s40262-023-01222-w","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"1681_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40266-022-00999-y","volume":"40","author":"A Eidam","year":"2023","unstructured":"Eidam\u00a0A, Marji\u00a0J, Benzinger\u00a0P, Foerster\u00a0KI, Burhenne\u00a0J, Czock\u00a0D, Stoll\u00a0F, Blank\u00a0A, Mikus\u00a0G, Haefeli\u00a0WE, Bauer\u00a0JM (2023) Frailty as a\u00a0marker for the plasma concentrations of direct oral anticoagulants in older patients: results of an exploratory study. Drugs Aging 40(2):153\u2013164. https:\/\/doi.org\/10.1007\/s40266-022-00999-y","journal-title":"Drugs Aging"},{"issue":"25","key":"1681_CR11","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/eurheartj\/ehz150","volume":"40","author":"S Ewen","year":"2019","unstructured":"Ewen\u00a0S, Mahfoud\u00a0F, B\u00f6hm\u00a0M (2019) Blood pressure targets in the elderly: many guidelines, much confusion. Eur Heart\u00a0J 40(25):2029\u20132031. https:\/\/doi.org\/10.1093\/eurheartj\/ehz150","journal-title":"Eur Heart J"},{"key":"1681_CR12","unstructured":"(2021) FORTA Liste. https:\/\/www.umm.uni-heidelberg.de\/experimentelle-pharmakologie\/research\/gruppe-wehling\/"},{"issue":"3","key":"1681_CR13","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.m146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried\u00a0LP, Tangen\u00a0CM, Walston\u00a0J, Newman\u00a0AB, Hirsch\u00a0C, Gottdiener\u00a0J, Seeman\u00a0T, Tracy\u00a0R, Kop\u00a0WJ, Burke\u00a0G, McBurnie\u00a0MA, Cardiovascular Health Study Collaborative Research Group (2001) Frailty in older adults: evidence for a\u00a0phenotype. J\u00a0Gerontol A Biol Sci Med Sci 56(3):M146\u201356. https:\/\/doi.org\/10.1093\/gerona\/56.3.m146 (PMID: 11253156)","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1681_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000159","author":"D Gnjidic","year":"2022","unstructured":"Gnjidic\u00a0D, Johansson\u00a0M, Meng\u00a0DM, Farrell\u00a0B, Langford\u00a0A, Reeve\u00a0E (2022) Achieving sustainable healthcare through deprescribing. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.ED000159","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1681_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/ehjqcco\/qcad019","volume":"10","author":"M Grymonprez","year":"2024","unstructured":"Grymonprez\u00a0M, Petrovic\u00a0M, De Backer\u00a0TL, Steurbaut\u00a0S, Lahousse\u00a0L (2024) Impact of frailty on the effectiveness and safety of non-vitamin\u00a0K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a\u00a0nationwide cohort study. Eur Heart J Qual Care Clin Outcomes 10(1):55\u201365. https:\/\/doi.org\/10.1093\/ehjqcco\/qcad019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"7","key":"1681_CR16","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2468-2667(18)30091-4","volume":"3","author":"P Hanlon","year":"2018","unstructured":"Hanlon\u00a0P, Nicholl\u00a0BI, Jani\u00a0BD, Lee\u00a0D, McQueenie\u00a0R, Mair\u00a0FS (2018) Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a\u00a0prospective analysis of 493 737 UK Biobank participants. Lancet Public Health 3(7):e323\u2013e332. https:\/\/doi.org\/10.1016\/S2468-2667(18)30091-4","journal-title":"Lancet Public Health"},{"issue":"7170","key":"1681_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/450603a","volume":"450","author":"EC Hayden","year":"2007","unstructured":"Hayden\u00a0EC (2007) A new angle on \u201cold\u201d. Nature 450(7170):603\u2013605","journal-title":"Nature"},{"issue":"4","key":"1681_CR18","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/ageing\/afab003","volume":"50","author":"SN Hilmer","year":"2021","unstructured":"Hilmer\u00a0SN, Kirkpatrick\u00a0CMJ (2021) New Horizons in the impact of frailty on pharmacokinetics: latest developments. Age Ageing 50(4):1054\u20131063. https:\/\/doi.org\/10.1093\/ageing\/afab003","journal-title":"Age Ageing"},{"issue":"4","key":"1681_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.123.066485","volume":"149","author":"LPT Joosten","year":"2024","unstructured":"Joosten\u00a0LPT, van Doorn\u00a0S, van de Ven\u00a0PM, K\u00f6hlen\u00a0BTG, Nierman\u00a0MC, Koek\u00a0HL, Hemels\u00a0MEW, Huisman\u00a0MV, Kruip\u00a0M, Faber\u00a0LM, Wiersma\u00a0NM, Buding\u00a0WF, Fijnheer\u00a0R, Adriaansen\u00a0HJ, Roes\u00a0KC, Hoes\u00a0AW, Rutten\u00a0FH, Geersing\u00a0GJ (2024) Safety of switching from a\u00a0vitamin\u00a0K antagonist to a\u00a0non-vitamin\u00a0K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation 149(4):279\u2013289. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066485","journal-title":"Circulation"},{"issue":"8","key":"1681_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/jamainternmed.2016.3057","volume":"176","author":"HA Kooistra","year":"2016","unstructured":"Kooistra\u00a0HA, Calf\u00a0AH, Piersma-Wichers\u00a0M, Kluin-Nelemans\u00a0HC, Izaks\u00a0GJ, Veeger\u00a0NJ, Meijer\u00a0K (2016) Risk of bleeding and thrombosis in patients 70 years or older using vitamin\u00a0K antagonists. JAMA Intern Med 176(8):1176\u20131183. https:\/\/doi.org\/10.1001\/jamainternmed.2016.3057","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1681_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.121.17530","volume":"79","author":"KM Kremer","year":"2022","unstructured":"Kremer\u00a0KM, Braisch\u00a0U, Rothenbacher\u00a0D, Denkinger\u00a0M, Dallmeier\u00a0D, ActiFE Study Group (2022) Systolic blood pressure and mortality in community-dwelling older adults: frailty as an effect modifier. Hypertension 79(1):24\u201332. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17530","journal-title":"Hypertension"},{"issue":"9","key":"1681_CR22","doi-asserted-by":"publisher","first-page":"e050344","DOI":"10.1136\/bmjopen-2021-050344","volume":"11","author":"C Kr\u00fcger","year":"2021","unstructured":"Kr\u00fcger\u00a0C, Sch\u00e4fer\u00a0I, van den Bussche\u00a0H, Bickel\u00a0H, Dreischulte\u00a0T, Fuchs\u00a0A, K\u00f6nig\u00a0HH, Maier\u00a0W, Mergenthal\u00a0K, Riedel-Heller\u00a0SG, Sch\u00f6n\u00a0G, Weyerer\u00a0S, Wiese\u00a0B, von Renteln-Kruse\u00a0W, Langebrake\u00a0C, Scherer\u00a0M (2021) Comparison of FORTA, PRISCUS and EU(7)-PIM lists on identifying potentially inappropriate medication and its impact on cognitive function in multimorbid elderly German people in primary care: a\u00a0multicentre observational study. Bmj Open 11(9):e50344. https:\/\/doi.org\/10.1136\/bmjopen-2021-050344","journal-title":"Bmj Open"},{"issue":"7","key":"1681_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.carrev.2019.11.009","volume":"21","author":"CS Kwok","year":"2020","unstructured":"Kwok\u00a0CS, Achenbach\u00a0S, Curzen\u00a0N, Fischman\u00a0DL, Savage\u00a0M, Bagur\u00a0R, Kontopantelis\u00a0E, Martin\u00a0GP, Steg\u00a0PG, Mamas\u00a0MA (2020) Relation of frailty to outcomes in percutaneous coronary intervention. Cardiovasc Revasc Med 21(7):811\u2013818. https:\/\/doi.org\/10.1016\/j.carrev.2019.11.009","journal-title":"Cardiovasc Revasc Med"},{"issue":"10248","key":"1681_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston\u00a0G, Huntley\u00a0J, Sommerlad\u00a0A, Ames\u00a0D, Ballard\u00a0C, Banerjee\u00a0S, Brayne\u00a0C, Burns\u00a0A, Cohen-Mansfield\u00a0J, Cooper\u00a0C, Costafreda\u00a0SG, Dias\u00a0A, Fox\u00a0N, Gitlin\u00a0LN, Howard\u00a0R, Kales\u00a0HC, Kivim\u00e4ki\u00a0M, Larson\u00a0EB, Ogunniyi\u00a0A, Orgeta\u00a0V, Ritchie\u00a0K, Rockwood\u00a0K, Sampson\u00a0EL, Samus\u00a0Q, Schneider\u00a0LS, Selb\u00e6k\u00a0G, Teri\u00a0L, Mukadam\u00a0N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396(10248):413\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6 (Erratum in: Lancet. 2023 Sep 30;402(10408):1132)","journal-title":"Lancet"},{"issue":"6","key":"1681_CR25","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn\u00a0C, Blasco\u00a0MA, Partridge\u00a0L, Serrano\u00a0M, Kroemer\u00a0G (2013) The hallmarks of aging. Cell 153(6):1194\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2013.05.039","journal-title":"Cell"},{"issue":"1\u20132","key":"1681_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3238\/arztebl.m2022.0377","volume":"120","author":"NK Mann","year":"2023","unstructured":"Mann\u00a0NK, Mathes\u00a0T, S\u00f6nnichsen\u00a0A, Pieper\u00a0D, Klager\u00a0E, Moussa\u00a0M, Th\u00fcrmann\u00a0PA (2023) Potentially Inadequate Medications in the Elderly: PRISCUS 2.0. Dtsch \u00c4rztebl Int 120(1\u20132):3\u201310. https:\/\/doi.org\/10.3238\/arztebl.m2022.0377","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1681_CR27","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M, Gardner\u00a0RS, Baumbach\u00a0A, B\u00f6hm\u00a0M et\u00a0al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart\u00a0J 42:3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"1681_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","volume":"78","author":"L Mid\u00e3o","year":"2018","unstructured":"Mid\u00e3o\u00a0L, Giardini\u00a0A, Menditto\u00a0E, Kardas\u00a0P, Costa\u00a0E (2018) Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr 78:213\u2013220. https:\/\/doi.org\/10.1016\/j.archger.2018.06.018","journal-title":"Arch Gerontol Geriatr"},{"issue":"7","key":"1681_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/archinte.159.7.677","volume":"159","author":"M Man-Son-Hing","year":"1999","unstructured":"Man-Son-Hing\u00a0M, Nichol\u00a0G, Lau\u00a0A, Laupacis\u00a0A (1999) Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 159(7):677\u2013685. https:\/\/doi.org\/10.1001\/archinte.159.7.677","journal-title":"Arch Intern Med"},{"issue":"6","key":"1681_CR30","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s11357-022-00605-4","volume":"44","author":"JM Moen","year":"2022","unstructured":"Moen\u00a0JM, Morrell\u00a0CH, Matt\u00a0MG, Ahmet\u00a0I, Tagirova\u00a0S, Davoodi\u00a0M, Petr\u00a0M, Charles\u00a0S, de Cabo\u00a0R, Yaniv\u00a0Y, Lakatta\u00a0EG (2022) Emergence of heartbeat frailty in advanced age I:\u00a0perspectives from life-long EKG recordings in adult mice. Geroscience 44(6):2801\u20132830. https:\/\/doi.org\/10.1007\/s11357-022-00605-4","journal-title":"Geroscience"},{"key":"1681_CR31","unstructured":"(2023) Nationale Versorgungsleitlinie Hypertonie. https:\/\/www.leitlinien.de\/themen\/hypertonie"},{"issue":"6","key":"1681_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","volume":"14","author":"JE Morley","year":"2013","unstructured":"Morley\u00a0JE, Vellas\u00a0B, van Kan\u00a0GA, Anker\u00a0SD, Bauer\u00a0JM, Bernabei\u00a0R, Cesari\u00a0M, Chumlea\u00a0WC, Doehner\u00a0W, Evans\u00a0J, Fried\u00a0LP, Guralnik\u00a0JM, Katz\u00a0PR, Malmstrom\u00a0TK, McCarter\u00a0RJ, Gutierrez Robledo\u00a0LM, Rockwood\u00a0K, von Haehling\u00a0S, Vandewoude\u00a0MF, Walston\u00a0J (2013) Frailty consensus: a\u00a0call to action. J\u00a0Am Med Dir Assoc 14(6):392\u2013397. https:\/\/doi.org\/10.1016\/j.jamda.2013.03.022","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"1681_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3238\/arztebl.2019.0023","volume":"116","author":"V M\u00fchlbauer","year":"2019","unstructured":"M\u00fchlbauer\u00a0V, Dallmeier\u00a0D, Brefka\u00a0S, Bollig\u00a0C, Voigt-Radloff\u00a0S, Denkinger\u00a0M (2019) The pharmacological treatment of arterial hypertension in frail, older patients\u2014a systematic review. Dtsch \u00c4rztebl Int 116(3):23\u201330. https:\/\/doi.org\/10.3238\/arztebl.2019.0023","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"3","key":"1681_CR34","doi-asserted-by":"publisher","first-page":"M158","DOI":"10.1093\/gerona\/56.3.m158","volume":"56","author":"AB Newman","year":"2001","unstructured":"Newman\u00a0AB, Gottdiener\u00a0JS, Mcburnie\u00a0MA, Hirsch\u00a0CH, Kop\u00a0WJ, Tracy\u00a0R, Walston\u00a0JD, Fried\u00a0LP, Cardiovascular Health Study Research Group (2001) Associations of subclinical cardiovascular disease with frailty. J\u00a0Gerontol A Biol Sci Med Sci 56(3):M158\u2013M166. https:\/\/doi.org\/10.1093\/gerona\/56.3.m158","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"1681_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jchf.2019.10.005","volume":"7","author":"A Pandey","year":"2019","unstructured":"Pandey\u00a0A, Kitzman\u00a0D, Reeves\u00a0G (2019) Frailty is intertwined with heart failure: mechanisms, prevalence, prognosis, assessment, and management. JACC Heart Fail 7(12):1001\u20131011. https:\/\/doi.org\/10.1016\/j.jchf.2019.10.005","journal-title":"JACC Heart Fail"},{"issue":"3","key":"1681_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan\u00a0F, Wehling\u00a0M (2021) Polypharmacy in older adults: a\u00a0narrative review of definitions, epidemiology and consequences. Eur Geriatr Med 12(3):443\u2013452. https:\/\/doi.org\/10.1007\/s41999-021-00479-3","journal-title":"Eur Geriatr Med"},{"key":"1681_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-physiol-021119-034453","volume":"82","author":"CH Peters","year":"2020","unstructured":"Peters\u00a0CH, Sharpe\u00a0EJ, Proenza\u00a0C (2020) Cardiac pacemaker activity and aging. Annu Rev Physiol 82:21\u201343. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034453","journal-title":"Annu Rev Physiol"},{"issue":"9085","key":"1681_CR38","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(05)63817-2","volume":"350","author":"NM Resnick","year":"1997","unstructured":"Resnick\u00a0NM, Marcantonio\u00a0ER (1997) How should clinical care of the aged differ? Lancet 350(9085):1157\u20131158. https:\/\/doi.org\/10.1016\/S0140-6736(05)63817-2","journal-title":"Lancet"},{"issue":"1","key":"1681_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/eurjpc\/zwaa167","volume":"29","author":"D Richter","year":"2022","unstructured":"Richter\u00a0D, Guasti\u00a0L, Walker\u00a0D, Lambrinou\u00a0E, Lionis\u00a0C, Abreu\u00a0A, Savelieva\u00a0I, Fumagalli\u00a0S, Bo\u00a0M, Rocca\u00a0B, Jensen\u00a0MT, Pierard\u00a0L, Sudano\u00a0I, Aboyans\u00a0V, Asteggiano\u00a0R (2022) Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A\u00a0consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e\u2011Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS). Eur J Prev Cardiol 29(1):216\u2013227. https:\/\/doi.org\/10.1093\/eurjpc\/zwaa167","journal-title":"Eur J Prev Cardiol"},{"issue":"20","key":"1681_CR40","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jama.2020.4871","volume":"323","author":"JP Sheppard","year":"2020","unstructured":"Sheppard\u00a0JP, Burt\u00a0J, Lown\u00a0M, Temple\u00a0E, Lowe\u00a0R, Fraser\u00a0R, Allen\u00a0J, Ford\u00a0GA, Heneghan\u00a0C, Hobbs\u00a0FDR, Jowett\u00a0S, Kodabuckus\u00a0S, Little\u00a0P, Mant\u00a0J, Mollison\u00a0J, Payne\u00a0RA, Williams\u00a0M, Yu\u00a0LM, McManus\u00a0RJ, OPTIMISE Investigators (2020) Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older: the OPTIMISE randomized clinical trial. JAMA 323(20):2039\u20132051. https:\/\/doi.org\/10.1001\/jama.2020.4871","journal-title":"JAMA"},{"issue":"11","key":"1681_CR41","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/jgs.16749","volume":"68","author":"JP Sheppard","year":"2020","unstructured":"Sheppard\u00a0JP, Lown\u00a0M, Burt\u00a0J, Temple\u00a0E, Lowe\u00a0R, Ashby\u00a0H, Todd\u00a0O, Allen\u00a0J, Ford\u00a0GA, Fraser\u00a0R, Heneghan\u00a0C, Hobbs\u00a0FDR, Jowett\u00a0S, Little\u00a0P, Mant\u00a0J, Mollison\u00a0J, Payne\u00a0R, Williams\u00a0M, Yu\u00a0LM, McManus\u00a0RJ (2020) Generalizability of blood pressure lowering trials to older patients: cross-sectional analysis. J\u00a0Am Geriatr Soc 68(11):2508\u20132515. https:\/\/doi.org\/10.1111\/jgs.16749","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1681_CR42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jacc.2021.10.037","volume":"79","author":"AS Volgman","year":"2022","unstructured":"Volgman\u00a0AS, Nair\u00a0G, Lyubarova\u00a0R, Merchant\u00a0FM, Mason\u00a0P, Curtis\u00a0AB, Wenger\u00a0NK, Aggarwal\u00a0NT, Kirkpatrick\u00a0JN, Benjamin\u00a0EJ (2022) Management of atrial fibrillation in patients 75 years and older: JACC state-of-the-art review. J\u00a0Am Coll Cardiol 79(2):166\u2013179. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.037 (Erratum in: J Am Coll Cardiol. 2022 May 17;79(19):1967)","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1681_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40266-021-00870-6","volume":"38","author":"W Wei","year":"2021","unstructured":"Wei\u00a0W, Rasu\u00a0RS, Hern\u00e1ndez-Mu\u00f1oz\u00a0JJ, Flores\u00a0RJ, Rianon\u00a0NJ, Hern\u00e1ndez-Vizcarrondo\u00a0GA, Brown\u00a0AT (2021) Impact of fall risk and direct oral anticoagulant treatment on quality-adjusted life-years in older adults with atrial fibrillation: a\u00a0Markov decision analysis. Drugs Aging 38(8):713\u2013723. https:\/\/doi.org\/10.1007\/s40266-021-00870-6","journal-title":"Drugs Aging"},{"key":"1681_CR44","unstructured":"WHO Medication safety in polypharmacy: technical report. https:\/\/www.who.int\/publications\/i\/item\/WHO-UHC-SDS-2019.11 (Erstellt: 20. Juni 2019)"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01681-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T06:02:50Z","timestamp":1714370570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01681-8"}},"subtitle":["Gibt es neue Erkenntnisse und Empfehlungen?","Are there any new insights and recommendations?"],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1681"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01681-8","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"9 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0M\u00fcller-Werdan gibt an, dass sie in den letzten Jahren Vortragshonorare erhalten hat von Assistenz3, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Novartis, Paul-Martini-Stiftung, Pfizer, ThermoFisher und Sch\u00e4fer Events.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}